cefTAZidim DR. Eberth
dosage/strength | dosage form | pack size |
| pharmaceutical registration number | SmPC |
|---|---|---|---|---|---|
0,5 g | powder for solution for injection | 10 vials | N3 | 11281953 |
|
1 g | powder for solution for injection / infusion | 5 vials | N2 | 11281976 |
|
powder for solution for injection / infusion | 10 vials | N3 | 11281982 | ||
2 g
| powder for solution for injection / infusion | 5 vials | N2 | 11281999 |
|
powder for solution for injection / infusion | 10 vials | N3 | 11282007 |
Active substance:
Ceftazidime 5 H2O
Pharmacotherapeutic group:
Antibacterials for systemic use, Third-generation cephalosporins,
ATC code: J01DD02
Mechanism of action:
Ceftazidime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death of the bacterias.
Therapeutic indications:
Ceftazidim Dr. Eberth is used in adults and children, including newborns (from birth), for infections listed below:
- Nosocomial pneumonia
- Broncho-pulmonary infections in cystic fibrosis
- Bacterial meningitis
- Chronic purulent otitis media
- Malignant otitis externa
- Complicated urinary tract infections
- Complicated skin and soft tissue infections
- Complicated intra-abdominal infections
- Infections of bone and joint
- Peritonitis associated with dialysis in CAPD patients
Treatment of patients with bacteremia associated or suspected to be associated with any of the above infections.
Ceftazidime can be used to treat neutropenic patients who have a fever due to a suspected bacterial infection.
Ceftazidime can be used as peri-operative prophylaxis of urinary tract infections in patients undergoing transurethral resection of the prostate (TURP).
When choosing ceftazidime, its antibacterial spectrum should be taken into account, which is mainly limited to aerobic Gram-negative bacteria.
Ceftazidime should be used together with other antibacterial substances if the possible range of causative bacteria is not covereed by the spectrum of activity of Ceftazidim Dr. Eberth.